David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$751M |
| 2 |
Advanced Micro Devices
AMD
|
+$751M |
| 3 |
Micron Technology
MU
|
+$426M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$363M |
| 5 |
ExxonMobil
XOM
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$546M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$485M |
| 3 |
VMW
VMware, Inc
VMW
|
+$393M |
| 4 |
Microsoft
MSFT
|
+$336M |
| 5 |
UnitedHealth
UNH
|
+$303M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.03% |
| 2 | Consumer Discretionary | 9.51% |
| 3 | Healthcare | 5.77% |
| 4 | Financials | 5.47% |
| 5 | Communication Services | 4.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1601
Ligand Pharmaceuticals
LGND
$5.62B
| $6.28M | 0.01% |
87,909
-17,812
| -17% | -$1.05M |
|
|
DCPH
1602
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $6.27M | 0.01% |
388,663
+71,702
| +23% | +$915K |
|
1603
PUT
Skywest
SKYW
$4.02B
| $6.26M | 0.01% |
120,000
| – | – |
|
1604
JFrog
FROG
$11B
| $6.25M | 0.01% |
180,541
+58,568
| +48% | +$1.58M |
|
1605
CALL
Fluor
FLR
$6.86B
| $6.25M | 0.01% |
159,500
+17,500
| +12% | +$647K |
|
1606
WEX
WEX
$6.81B
| $6.24M | 0.01% |
32,064
+21,610
| +207% | +$3.92M |
|
1607
CALL
Lowe's Companies
LOW
$120B
| $6.23M | 0.01% |
28,000
+8,000
| +40% | +$1.62M |
|
1608
Burford Capital
BUR
$982M
| $6.2M | 0.01% |
397,646
-466,218
| -54% | -$6.23M |
|
1609
PUT
Agnico Eagle Mines
AEM
$113B
| $6.2M | 0.01% |
113,000
| – | – |
|
1610
Cerus
CERS
$548M
| $6.19M | 0.01% |
2,867,711
-295,075
| -9% | -$486K |
|
1611
Biogen
BIIB
$32.6B
| $6.19M | 0.01% |
23,935
-254,903
| -91% | -$62.6M |
|
1612
Symbotic
SYM
$5.25B
| $6.18M | 0.01% |
120,407
+89,234
| +286% | +$3.91M |
|
1613
CALL
Take-Two Interactive
TTWO
$43.6B
| $6.16M | 0.01% |
38,300
| – | – |
|
|
CCC
1614
CCC Intelligent Solutions
CCC
$4.39B
| $6.16M | 0.01% |
541,013
+349,632
| +183% | +$4.08M |
|
1615
Plains GP Holdings
PAGP
$5.38B
| $6.16M | 0.01% |
+386,158
| New | +$6.1M |
|
1616
SLM Corp
SLM
$4.98B
| $6.15M | 0.01% |
321,486
-287,262
| -47% | -$4.34M |
|
1617
Edgewell Personal Care
EPC
$1.33B
| $6.13M | 0.01% |
167,387
+22,894
| +16% | +$810K |
|
1618
White Mountains Insurance
WTM
$5.11B
| $6.1M | 0.01% |
4,051
+300
| +8% | +$446K |
|
1619
Griffon
GFF
$4.59B
| $6.09M | 0.01% |
99,929
+71,051
| +246% | +$3.28M |
|
1620
Digimarc Corp
DMRC
$131M
| $6.07M | 0.01% |
168,161
+11,619
| +7% | +$368K |
|
1621
Albany International
AIN
$1.65B
| $6.07M | 0.01% |
61,786
-20,371
| -25% | -$1.78M |
|
|
BLD
1622
DELISTED
TopBuild
BLD
| $6.06M | 0.01% |
16,198
-641
| -4% | -$184K |
|
1623
PUT
Duolingo
DUOL
$6.83B
| $6.06M | 0.01% |
26,700
+16,700
| +167% | +$3.25M |
|
|
KRTX
1624
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $6.06M | 0.01% |
19,131
-20,353
| -52% | -$3.96M |
|
1625
CALL
Allegro MicroSystems
ALGM
$6.98B
| $6.05M | 0.01% |
200,000
+150,000
| +300% | +$4.28M |
|
Similar funds
David Shaw's Q4 2023 Portfolio in Review
As of Q4 2023, David Shaw held 4,806 positions worth $114B, up 19% from $95.8B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
David Shaw's Q4 2023 filing shows 575 new, 1,549 increased, 1,464 reduced and 527 closed positions. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M. The largest sale was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $546M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- David Shaw's largest Q4 2023 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M.
- David Shaw added most to Netflix in Q4 2023, an estimated $751M increase.
- David Shaw's biggest Q4 2023 reduction was Microsoft, cutting an estimated $336M.
- David Shaw fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $546M.
- David Shaw's ten largest holdings make up 12% of its $114B portfolio in Q4 2023.
- David Shaw opened 575 new positions and closed 527 in Q4 2023.
- David Shaw's portfolio value rose 19% quarter-over-quarter to $114B.
Based on D.E. Shaw & Co's 13F filing for Q4 2023, filed 14 Feb 2024.